Weight measurements and disease-specific growth charts to predict clinical outcomes in children with cerebral palsy | Judy-April Murayi & Praveen Goday | DMCN

In this episode of the DMCN Journal podcast, Dr. Judy April Morai and Dr. Praveen Gadeh discuss their recent study published in the Journal of Developmental Medicine and Child Neurology, which investigates the clinical significance of weight measurements and disease-specific growth charts in children with cerebral palsy (CP). The episode highlights the limitations of standard growth charts for children with CP, which are based on typically developing children and fail to account for differences in body composition, mobility, and energy expenditure. Instead, the authors focus on CP-specific growth charts developed in 2011, which stratify children by GMFCS level and use the 20th percentile as a potential benchmark. Their retrospective cohort study of 127 children with moderate to severe CP (GMFCS levels 3–5) over five and a half years found that those consistently below the 20th percentile had significantly higher rates of emergency department visits, longer PICU stays, and dramatically higher mortality—28.6% versus 4.4%—especially among the most severely affected (GMFCS level 5). While the mortality difference did not reach statistical significance due to small sample size, the survival curve showed a stark divergence. The authors conclude that the 20th percentile may serve as a clinically meaningful marker, though it remains unclear whether low weight causes poor outcomes or is merely a reflection of underlying illness severity. They call for prospective studies to determine if nutritional interventions that raise weight above the 20th percentile can improve clinical outcomes. Key takeaways include: (1) The 20th percentile on CP-specific growth charts is a clinically relevant threshold for identifying children at higher risk; (2) Children below this threshold experience significantly more urgent care visits and longer PICU stays; (3) Mortality is dramatically higher in children below the 20th percentile, particularly at the most severe GMFCS levels; (4) Weight trajectories are stable over time, suggesting early nutritional intervention may be critical; (5) Low weight may be both a marker and a modifiable factor, warranting further research. The episode underscores the importance of using disease-specific tools in pediatric neurology and calls for a shift toward proactive nutritional support in high-risk CP populations.